Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'pi3 kinase p110'

Search results for: 'pi3 kinase p110'

Items 1-10 of 14

Page
per page
  1. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  2. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor,highly potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
  3. R788 disodium
    A8332 R788 disodium
    Target: Syk
    Summary: Syk inhibitor,ATP competitive and potent
      ≥62.4 mg/mL
  4. Fenretinide
    A3412 Fenretinide
    Target: FAK
    Summary: Synthetic retinoid agonist
      insoluble in H2O; ≥19.6 mg/mL
  5. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL
  6. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  7. Dinaciclib (SCH727965)
    A8412 Dinaciclib (SCH727965)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Potent CDK inhibitor
  8. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  9. PHA-793887
    A5459 PHA-793887
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Pan-Cdk inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  10. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL

Items 1-10 of 14

Page
per page